Moderate weight loss reduces renin and aldosterone but does not influence basal or stimulated pituitary-adrenal axis function

Hormone and Metabolic Research

Volumn 39, Issue 9, 2007, Pages 694-699

  Ho, J T ^a,b   Keogh, J B ^c   Bornstein, S R ^d   Ehrhart Bornstein, M ^d   Lewis, J G ^e   Clifton, P M ^c   Torpy, D J ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b HANSON INSTITUTE   (Australia)

^c CSIRO   (Australia)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

Aldosterone; Blood pressure; Cortisol; Obesity; Weight loss

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; CORTISONE; RENIN; TRANSCORTIN;

ADULT; AGED; BODY MASS; CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; URINALYSIS; WEIGHT REDUCTION;

ADULT; AGED; ALDOSTERONE; BLOOD PRESSURE; BODY WEIGHT; CALORIC RESTRICTION; COSYNTROPIN; CROSS-OVER STUDIES; DIET, REDUCING; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; OBESITY; PITUITARY-ADRENAL SYSTEM; RENIN; RENIN-ANGIOTENSIN SYSTEM; SODIUM CHLORIDE, DIETARY; TRANSCORTIN; WEIGHT LOSS;

EID: 34848866955     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985354     Document Type: Conference Paper

References (31)

1. Kannel WB, Garrison RJ, Dannenberg AL. Secular blood pressure trends in normotensive persons: the Framingham Study. Am Heart J 1993; 125: 1154-1158
2. Aucott L, Poobalan A, Smith WC, Avenell A, Jung R, Broom J. Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension 2005; 45: 1035-1041
3. Berchtold P, Sims EA, Horton ES, Berger M. Obesity and hypertension: epidemiology, mechanisms, treatment. Biomed Pharmacother 1983; 37: 251-258
4. Dornfeld LP, Maxwell MH, Waks A, Tuck M. Mechanisms of hypertension in obesity. Kidney Int Suppl 1987; 22: S254-S258
5. El Atat F, Aneja A, Macfarlane S, Sowers J. Obesity and hypertension. Endocrinol Metab Clin North Am 2003; 32: 823-854
6. Rocchini AP. Obesity hypertension. Am J Hypertens 2002; 15 (2 Pt 2): 50S-52S
7. Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin North Am 2002; 31: 173-189
8. Rocchini AP, Moorehead C, DeRemer S, Goodfriend TL, Ball DL. Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension 1990; 15 (6 Pt 2): 861-866
9. Hiramatsu K, Yamada T, Ichikawa K, Izumiyama T, Nagata H. Changes in endocrine activities relative to obesity in patients with essential hypertension. J Am Geriatr Soc 1981; 29: 25-30
10. Lamounier-Zepter V, Rotthoff T, Ansurudeen I, Kopprasch S, Scherbaum WA, Ehrhart-Bornstein M et al. Increased aldosterone/renin quotient in obese hypertensive women: a novel role for low-density lipoproteins? Horm Metab Res 2006; 38: 471-475
11. Goodfriend TL, Egan BM, Kelley DE. Aldosterone in obesity. Endocr Res 1998; 24 (3-4): 789-796
12. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA 2003; 100: 14211-14216
13. Schinner S, Willenberg HS, Krause D, Schott M, Lamounier-Zepter V, Krug AW et al. Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway. Int J Obes (Lond) 2007; 31(5): 864-870
14. Krug A, Vleugels K, Schinner S, Lamounier-Zepter V, Ziegler CG, Bornstein SR et al. Human Adipocytes Induce an ERK1/2 MAPkinases - mediated Upregulation of Steroidogenic Acute Regulatory Protein (StAR) and an Angiotensin II - Sensitization in Human Adrenocortical Cells. Int J Obes 2007, in press
15. Marin P, Darin N, Amemiya T, Andersson B, Jern S, Bjorntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 1992; 41: 882-886
16. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993; 77: 341-346
17. Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998; 83: 1853-1859
18. Fernandez-Real JM, Pugeat M, Grasa M, Broch M, Vendrell J, Brun J et al. Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study. J Clin Endocrinol Metab 2002; 87: 4686-4690
19. Tomlinson JW, Moore JS, Clark PM, Holder G, Shakespeare L, Stewart PM. Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue. J Clin Endocrinol Metab 2004; 89: 2711-2716
20. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989; 321: 580-585
21. Yanovski JA, Yanovski SZ, Gold PW, Chrousos GP. Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss. J Clin Endocrinol Metab 1997; 82: 1874-1878
22. Vertes V, Genuth SM, Hazelton IM. Supplemented fasting as a large-scale outpatient program. JAMA 1977; 238: 2151-2153
23. Mattson MP, Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem 2005; 16: 129-137
24. Ho JT, Al Musalhi H, Chapman MJ, Quach T, Thomas PD, Bagley CJ et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab 2006; 91: 105-114
25. Lewis JG, Lewis MG, Elder PA. An enzyme-linked immunosorbent assay for corticosteroid-binding globulin using monoclonal and polyclonal antibodies: decline in CBG following synthetic ACTH. Clin Chim Acta 2003; 328 (1-2): 121-128
26. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005; 45: 356-362
27. Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 1989; 2 (3 Pt 2): 125S-132S
28. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996; 27 (3 pt 2): 481-490
29. Midley JP, Matthew G, Greenwood CMT, Logan AG. Effects of reduced dietary salt on blood pressure: A meta analysis of randomised controlled trials. J Amer Med Assoc 1996; 275: 1590-1597
30. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004; (3): CD004937
31. Sullivan JM. Salt sensitivity. Definition, conception, methodology, and long term issues. Hypertension 1991 Jan; 17 (1 Suppl): 161-168